Drug price controls in Biden’s proposed budget hurtful for patients, R&D

The 2024 budget proposal President Biden officially released yesterday is facing rocky ground ...

Congress shines a light on China’s strategy to steal U.S. IP

Experts told a House subcommittee Wednesday that China’s government coordinates a strategy to ...

U.S. takes step toward legal resolution of Mexico’s biotech corn ban

On March 6, 2023, the United States Trade Representative (USTR) made a request ...

Strong IP protection for seeds key to enabling biotech innovation

“Strong patents, and an efficient, predictable, and objective patent system, are critical to ...

national-cancer-institute-tl447mekwuQ-unsplash

Legislation potentially banning QALYs due to discrimination is under review

On March 8, 2023, during the first markup of health care bills this ...

Alzheimer’s drug LEQEMBI granted Priority Review for traditional approval

The breakthrough Alzheimer’s drug LEQEMBI could receive traditional Food and Drug Administration (FDA) ...

BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices

Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...

February 13, 2026

BIO lauds passage of PPRV reauthorization and legislation on PBM reform

February 4, 2026

A female nurse of African decent sits at the bedside of a female patient as she checks in on her during rounds. The patient is dressed comfortably and has a head scarf on to keep warm.

Putting Americans First: No medicine is more expensive than the one patients can’t access

September 12, 2025

LATEST NEWS

SBIR reauthorization, a top BIO priority, is passed by Congress

Reauthorization of federal seed funding, a top priority for BIO’s work with Congress, passed the House with hefty bipartisan support on March 17 and is ...

March 18, 2026

BIO's View

BIO on the American Road in Puerto Rico: ‘Medicine Cabinet’ ready to reshore

Known as “America’s Medicine Cabinet,” Puerto Rico is working to maintain its leadership in U.S. biotech production by becoming a hub for reshoring pharmaceutical manufacturing. ...

March 16, 2026

BIO Events

BIG Summit themes: Resilient investment, MFN threat, patients in the center

The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders in the biotech industry to catch up on domestic and international policy ...

March 16, 2026

BIO Events

BIG Summit panel breaks down risks and opportunities coming out of DC

Washington’s healthcare policy landscape is constantly evolving, and 2026 is shaping up to be another consequential year for the biotech industry. Some developments are positive, ...

March 13, 2026

BIO's View

The hidden layer of PBMs: What a recent investigation reveals

With health care affordability a top concern for many Americans, pharmacy benefit managers (PBMs) continue to stand at the center of the debate. Working with ...

March 9, 2026